Cyxone AB (Sweden) Market Value

CYXO Stock  SEK 0.14  0.01  7.69%   
Cyxone AB's market value is the price at which a share of Cyxone AB trades on a public exchange. It measures the collective expectations of Cyxone AB investors about its performance. Cyxone AB is selling for under 0.14 as of the 19th of June 2024; that is 7.69 percent increase since the beginning of the trading day. The stock's last reported lowest price was 0.13.
With this module, you can estimate the performance of a buy and hold strategy of Cyxone AB and determine expected loss or profit from investing in Cyxone AB over a given investment horizon. Check out Cyxone AB Correlation, Cyxone AB Volatility and Cyxone AB Alpha and Beta module to complement your research on Cyxone AB.
Symbol

Please note, there is a significant difference between Cyxone AB's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cyxone AB is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cyxone AB's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Cyxone AB 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cyxone AB's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cyxone AB.
0.00
05/20/2024
No Change 0.00  0.0 
In 30 days
06/19/2024
0.00
If you would invest  0.00  in Cyxone AB on May 20, 2024 and sell it all today you would earn a total of 0.00 from holding Cyxone AB or generate 0.0% return on investment in Cyxone AB over 30 days. Cyxone AB is related to or competes with Hansa Biopharma, Saniona AB, BioArctic, and Alligator Bioscience. Cyxone AB , a clinical biotech company, develops disease modifying therapies for rheumatoid arthritis and multiple scler... More

Cyxone AB Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cyxone AB's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cyxone AB upside and downside potential and time the market with a certain degree of confidence.

Cyxone AB Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Cyxone AB's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cyxone AB's standard deviation. In reality, there are many statistical measures that can use Cyxone AB historical prices to predict the future Cyxone AB's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cyxone AB's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.010.146.75
Details
Intrinsic
Valuation
LowRealHigh
0.010.106.72
Details
Naive
Forecast
LowNextHigh
00.156.76
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.080.120.15
Details

Cyxone AB Backtested Returns

Cyxone AB is out of control given 3 months investment horizon. Cyxone AB secures Sharpe Ratio (or Efficiency) of 0.17, which signifies that the company had a 0.17% return per unit of risk over the last 3 months. We were able to interpolate twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.1% are justified by taking the suggested risk. Use Cyxone AB Downside Deviation of 6.31, mean deviation of 4.48, and Risk Adjusted Performance of 0.0853 to evaluate company specific risk that cannot be diversified away. Cyxone AB holds a performance score of 13 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 0.0129, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cyxone AB's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cyxone AB is expected to be smaller as well. Use Cyxone AB sortino ratio, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to analyze future returns on Cyxone AB.

Auto-correlation

    
  -0.52  

Good reverse predictability

Cyxone AB has good reverse predictability. Overlapping area represents the amount of predictability between Cyxone AB time series from 20th of May 2024 to 4th of June 2024 and 4th of June 2024 to 19th of June 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cyxone AB price movement. The serial correlation of -0.52 indicates that about 52.0% of current Cyxone AB price fluctuation can be explain by its past prices.
Correlation Coefficient-0.52
Spearman Rank Test-0.27
Residual Average0.0
Price Variance0.0

Cyxone AB lagged returns against current returns

Autocorrelation, which is Cyxone AB stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cyxone AB's stock expected returns. We can calculate the autocorrelation of Cyxone AB returns to help us make a trade decision. For example, suppose you find that Cyxone AB has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Cyxone AB regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cyxone AB stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cyxone AB stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cyxone AB stock over time.
   Current vs Lagged Prices   
       Timeline  

Cyxone AB Lagged Returns

When evaluating Cyxone AB's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cyxone AB stock have on its future price. Cyxone AB autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cyxone AB autocorrelation shows the relationship between Cyxone AB stock current value and its past values and can show if there is a momentum factor associated with investing in Cyxone AB.
   Regressed Prices   
       Timeline  

Pair Trading with Cyxone AB

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cyxone AB position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyxone AB will appreciate offsetting losses from the drop in the long position's value.

Moving together with Cyxone Stock

  0.77CAMX Camurus ABPairCorr
  0.79HNSA Hansa Biopharma ABPairCorr

Moving against Cyxone Stock

  0.78NANOFS Nanoform Finland PlcPairCorr
  0.66SHB-B Svenska HandelsbankenPairCorr
  0.63SHB-A Svenska HandelsbankenPairCorr
  0.59SSAB-B SSAB ABPairCorr
  0.58SSAB-A SSAB ABPairCorr
The ability to find closely correlated positions to Cyxone AB could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cyxone AB when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cyxone AB - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cyxone AB to buy it.
The correlation of Cyxone AB is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cyxone AB moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cyxone AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cyxone AB can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Cyxone Stock Analysis

When running Cyxone AB's price analysis, check to measure Cyxone AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyxone AB is operating at the current time. Most of Cyxone AB's value examination focuses on studying past and present price action to predict the probability of Cyxone AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyxone AB's price. Additionally, you may evaluate how the addition of Cyxone AB to your portfolios can decrease your overall portfolio volatility.